Overall rank by patents
#743
Across all tracked assignees
USPTO PatentsView assignee record — 615 granted patents across 125 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR).
Fresenius Medical Care Deutschland GmbH has been granted 615 US utility patents between 2015 and 2025, placing Fresenius Medical Care Deutschland GmbH at rank #743 across all assignees tracked by PlainPatent. This portfolio spans 125 distinct Cooperative Patent Classification (CPC) subclasses, averaging 16.1 claims per patent with primary concentration in A61M (DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR). As a Foreign Corporation, Fresenius Medical Care Deutschland GmbH is one of the broader-portfolio assignees in the PatentsView dataset. The composite Innovation Score of 63.2/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.
Filing cadence tells the strategic story. Between 2020 and 2025 the company received 318 grants, compared with 297 in the 2015–2019 window — a +7% shift in five-year velocity. Steady filing volume suggests sustained innovation without dramatic pivots. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.
Claim depth and technology breadth together indicate competitive posture. Fresenius Medical Care Deutschland GmbH's 16.1 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while a diversified footprint across 100+ CPC subclasses spreads risk across many technology fronts. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Fresenius Medical Care Deutschland GmbH against peers pursuing similar technology classes.
Granted US patents 2015–2025 versus the largest corporate holders — this company marked ◀
SAMSUNG ELECTRONICS CO., LTD.
106,890 patents
International Business Machines Corporation
72,926 patents
Canon Kabushiki Kaisha
34,378 patents
LG ELECTRONICS INC.
32,607 patents
TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY LTD.
31,041 patents
Apple Inc.
30,560 patents
QUALCOMM Incorporated
30,354 patents
Intel Corporation
27,498 patents
Fresenius Medical Care Deutschland GmbH
615 patents
What this shows Fresenius holds 615 patents — placing it at rank #743 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 46 | 7.5% |
| 2016 | 65 | 10.6% |
| 2017 | 67 | 10.9% |
| 2018 | 52 | 8.5% |
| 2019 | 67 | 10.9% |
| 2020 | 60 | 9.8% |
| 2021 | 49 | 8.0% |
| 2022 | 63 | 10.2% |
| 2023 | 37 | 6.0% |
| 2024 | 67 | 10.9% |
| 2025 | 42 | 6.8% |
Top 15 of 125 technology areas
Overall rank by patents
#743
Across all tracked assignees
63.2 out of 100
Fresenius Medical Care Deutschland GmbH's primary CPC class — all holders and yearly trends
See where Fresenius Medical Care Deutschland GmbH ranks among the largest US patent assignees
Browse every CPC technology area by patent activity
The four dimensions behind the Innovation Score
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.